NRC Health income statement
In fiscal 2025, NRC Health reported revenue of $137m, down 4.0% on the year before, operating income of $22.6m (a 16.4% margin) and net income of $11.3m, or $50.00 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58 | 63 | 76 | 86 | 93 | 99 | 102 | 109 | 118 | 120 | 128 | 133 | 148 | 152 | 149 | 143 | 137 | 140 |
| Selling, general and administrative | 16 | 20 | 23 | 24 | 25 | 25 | 27 | 28 | 30 | 31 | 33 | 34 | 39 | 43 | 47 | 45 | 55 | 63 |
| Operating income | 14 | 14 | 19 | 23 | 25 | 28 | 26 | 31 | 34 | 35 | 43 | 43 | 50 | 47 | 40 | 35 | 23 | 15 |
| Interest expense | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 1 | 1 | 3 | 5 | 5 |
| Income before tax | 13 | 13 | 18 | 22 | 24 | 28 | 27 | 31 | 34 | 35 | 41 | 41 | 49 | 43 | 40 | 33 | 18 | 9 |
| Income tax | 5 | 5 | 7 | 7 | 9 | 10 | 10 | 11 | 11 | 5 | 8 | 4 | 11 | 11 | 9 | 8 | 6 | 4 |
| Net income | 8 | 12 | 12 | 15 | 15 | 18 | 18 | 21 | 23 | 30 | 32 | 37 | 37 | 32 | 31 | 25 | 11 | 6 |
| Diluted EPS | $1.26 | $1.26 | $1.69 | $2.17 | — | — | — | — | — | — | $1.26 | $1.45 | $1.46 | $1.27 | $1.25 | $1.04 | $50.00 | $0.26 |
| Diluted shares (average) | 7m | 7m | 7m | 7m | — | — | — | — | — | — | 26m | 26m | 26m | 25m | 25m | 24m | 22m | 22m |
| EBITDA | 18 | 19 | 24 | 27 | 29 | 32 | 31 | 35 | 39 | 41 | 49 | — | — | — | 46 | 41 | 30 | 23 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 37 | 34 | 34 | 35 | 35 | 35 | 35 |
| Selling, general and administrative | 11 | 11 | 10 | 18 | 12 | 14 | 13 | 23 |
| Operating income | 8 | 10 | 9 | 2 | 8 | 5 | 6 | −3 |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Income before tax | 7 | 9 | 8 | 1 | 6 | 3 | 4 | −5 |
| Income tax | 2 | 2 | 2 | 1 | 2 | 1 | 1 | −1 |
| Net income | 6 | 7 | 6 | −0 | 4 | 2 | 3 | −3 |
| Diluted EPS | $0.24 | $0.28 | $0.25 | −$0.01 | $0.18 | $49.57 | $0.14 | −$0.15 |
| EBITDA | 10 | 11 | 10 | 3 | 10 | 7 | 8 | −1 |
Compare with peers
- Ridgetech Inc. income statement
- Airsculpt Technologies, Inc. income statement
- Petmed Express Inc income statement
- SBC Medical Group Holdings Inc income statement
- DLH Holdings Corp. income statement
Head to head: NRC vs RDGTAIRS vs NRCNRC vs PETSNRC vs SBC
More: Health Care Services stocks compared, Health Care sector, rankings of US companies